SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
-11.22%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$253M
AUM Growth
+$253M
(-5.6%)
Cap. Flow
-$107M
Cap. Flow
% of AUM
-42.34%
Top 10 Holdings %
Top 10 Hldgs %
44%
Holding
60
New
10
Increased
18
Reduced
9
Closed
21
Top Buys
| 1 |
Cencora
COR
|
$12.6M |
| 2 |
Bristol-Myers Squibb
BMY
|
$11M |
| 3 |
McKesson
MCK
|
$9.22M |
| 4 |
Novo Nordisk
NVO
|
$8.16M |
| 5 |
Encompass Health
EHC
|
$7.73M |
Top Sells
| 1 |
Boston Scientific
BSX
|
$82.9M |
| 2 |
Tenet Healthcare
THC
|
$27.6M |
| 3 |
AbbVie
ABBV
|
$14M |
| 4 |
Baxter International
BAX
|
$12.5M |
| 5 |
Elevance Health
ELV
|
$8.31M |
Sector Composition
| 1 | Healthcare | 98.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Bristol-Myers Squibb
BMY
$96B
| $18.5M | 7.29% |
320,000
+190,000
| +146% | +$11M |
|
|
2
Cencora
COR
$56.5B
| $12.6M | 4.96% |
+40,000
| New | +$12.6M |
|
3
Smith & Nephew
SNN
$16.3B
| $12.1M | 4.79% |
135,187
+60,187
| +80% | +$5.41M |
|
4
Incyte
INCY
$16.5B
| $11.4M | 4.5% |
115,000
+75,000
| +188% | +$7.43M |
|
5
UnitedHealth
UNH
$281B
| $10.6M | 4.18% |
42,500
+15,000
| +55% | +$3.74M |
|
6
Danaher
DHR
$147B
| $10.2M | 4.02% |
115,000
+65,000
| +130% | +$5.75M |
|
7
AstraZeneca
AZN
$248B
| $10.1M | 4% |
75,000
-50,000
| -40% | -$6.76M |
|
|
8
McKesson
MCK
$85.4B
| $9.22M | 3.64% |
+32,500
| New | +$9.22M |
|
9
BioMarin Pharmaceuticals
BMRN
$11.2B
| $8.39M | 3.31% |
235,000
+155,000
| +194% | +$5.53M |
|
10
Centene
CNC
$14.3B
| $8.39M | 3.31% |
175,000
+40,000
| +30% | +$1.92M |
|
|
11
Novo Nordisk
NVO
$251B
| $8.16M | 3.22% |
+250,000
| New | +$8.16M |
|
|
12
Encompass Health
EHC
$12.3B
| $7.73M | 3.05% |
+32,500
| New | +$7.73M |
|
13
HCA Healthcare
HCA
$94.5B
| $7.5M | 2.96% |
95,000
+32,500
| +52% | +$2.56M |
|
14
Cigna
CI
$80.3B
| $7.49M | 2.96% |
45,000
+5,000
| +13% | +$832K |
|
15
Cardinal Health
CAH
$35.5B
| $7.31M | 2.88% |
+90,000
| New | +$7.31M |
|
16
Intuitive Surgical
ISRG
$170B
| $6.99M | 2.76% |
485,523
+473,023
| +3,784% | +$6.81M |
|
17
Stryker
SYK
$150B
| $6.94M | 2.74% |
50,000
+25,000
| +100% | +$3.47M |
|
18
Humana
HUM
$36.5B
| $6.92M | 2.73% |
50,000
+22,500
| +82% | +$3.11M |
|
19
Universal Health Services
UHS
$11.6B
| $6.54M | 2.58% |
65,000
+10,000
| +18% | +$1.01M |
|
20
Biogen
BIIB
$19.4B
| $6.33M | 2.5% |
20,000
| – | – |
|
|
CTLT
21
DELISTED
CATALENT, INC.
CTLT
| $6.02M | 2.38% |
+100,000
| New | +$6.02M |
|
22
Merck
MRK
$210B
| $5.12M | 2.02% |
80,000
+5,000
| +7% | +$320K |
|
23
Abbott
ABT
$231B
| $5M | 1.97% |
65,000
+5,000
| +8% | +$385K |
|
24
Perrigo
PRGO
$3.27B
| $4.95M | 1.95% |
+65,000
| New | +$4.95M |
|
25
Regeneron Pharmaceuticals
REGN
$61.5B
| $4.88M | 1.93% |
10,000
-10,000
| -50% | -$4.88M |
|